Intravitreous injection of bevacizumab for chronic central serous chorioretinopathy.

MLA

Teng, Yu-Ti, et al. “Intravitreous Injection of Bevacizumab for Chronic Central Serous Chorioretinopathy.” Taiwan Journal of Ophthalmology, vol. 3, no. 2, June 2013, pp. 67–70. EBSCOhost, https://doi.org/10.1016/j.tjo.2013.04.001.

APA

Teng, Y.-T., Chen, C.-H., Lee, J.-J., Kuo, H.-K., & Wu, P.-C. (2013). Intravitreous injection of bevacizumab for chronic central serous chorioretinopathy. Taiwan Journal of Ophthalmology, 3(2), 67–70. https://doi.org/10.1016/j.tjo.2013.04.001

Chicago

Teng, Yu-Ti, Chih-Hsin Chen, Jong-Jer Lee, Hsi-Kung Kuo, and Pei-Chang Wu. 2013. “Intravitreous Injection of Bevacizumab for Chronic Central Serous Chorioretinopathy.” Taiwan Journal of Ophthalmology 3 (2): 67–70. doi:10.1016/j.tjo.2013.04.001.